Steven W. Millward
0000-0002-3231-7075
Publication & Citation Trends
Publications
0 total
Abstract 357: DIRAS3 mimetic peptide achieves dual MAPK and PI3K pathway suppression across KRAS hotspot mutations.
Cited by 0
Semantic Scholar
Targeted Molecular MRI of Colorectal Cancer by Antibody Functionalized Hyperpolarized Silicon Particles
Cited by 0
Semantic Scholar
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumors
Cited by 0
Semantic Scholar
Can the Discovery of High-Impact Diagnostics Be Improved by Matching the Sampling Rate of Clinical Diagnostics to the Frequency Domain of Diagnostic Information? OA
Cited by 0
Semantic Scholar
Directional conjugation of monoclonal antibodies to nanoparticles using metal-free click chemistry.
Cited by 1
Semantic Scholar
Using extension‐based mRNA display to design antibody‐like proteinogenic peptides for human PD‐L1
Cited by 0
Semantic Scholar
In vivo scanning laser fundus and high-resolution OCT imaging of retinal ganglion cell injury in a non-human primate model with an activatable fluorescent-labeled TAT peptide probe OA
Cited by 0
Semantic Scholar
Enolase inhibitors as therapeutic leads for Naegleria fowleri infection OA
Cited by 4
Semantic Scholar
Research Topics
Monoclonal and Polyclonal Antibodies Research
(17)
Cancer, Hypoxia, and Metabolism
(15)
Chemical Synthesis and Analysis
(11)
Click Chemistry and Applications
(11)
Advanced NMR Techniques and Applications
(11)
Affiliations
AstraZeneca (United Kingdom)
California Institute of Technology
The University of Texas MD Anderson Cancer Center
Max Planck Society
St. Anne's Health Centre